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ABSTRACT 
 
Aim: to compare antimicrobial efficacy of three different non-chlorhexidine non-alcohol 
containing mouthrinses. 
Objectives: to test antimicrobial efficacy of Colgate total®, Biobalance mouthwash® and 
Listerine Zero® against Streptococcus mutans, Staphylococcus aureus, Candida albicans, 
Enterococcus faecalis and the aerobic and facultative anaerobic organisms cultured from the 
collected oral saliva. 
Materials and methods: fourteen saliva samples were collected from staff members who fit the 
inclusion criteria along with fourteen pure cultures of each of the tested microorganisms. All 
samples were cultured in agar plates. Four sterile, 5mm discs were used for each plate, each 
representing one of the tested mouthrinses. Each disc was immersed for one minute and then 
deposited on sterile gauze to remove excess fluid. Then plates were incubated for 24 hours at 37 ̊ 
Celsius. Inhibition zones created around the discs were measured using an electronic caliber. 
Results: most of the tested mouthrinses showed antimicrobial efficacy against tested 
microorganism. Differences between them were statistically significant (p. value =0.0001). The 
order in terms of antimicrobial efficacy was Colgate total®˃ Biobalance mouthwash® ˃ 
Listerine Zero®. 
Conclusion: Colgate total® showed antimicrobial efficacy against all tested microorganisms. 
Whereas Biobalance mouthwash® failed to obtain significant antimicrobial efficacy against 
Enterococcus faecalis.  Listerine Zero® failed to accomplish significant results, the reason 
behind that is unknown.  
Keywords: Antimicrobial – efficacy – non-chlorhexidine – non-alcohol – mouthrinses.  
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CHAPTER 1 
Introduction and Literature review 
1.1 Introduction: 
It is generally accepted that adherence of plaque to hard and soft tissues of the mouth can cause 
gingivitis and dental caries. Several approaches have been used to reduce dental plaque (Gaffar 
et al, 1997).  
Most adults who stick to the two minutes tooth brushing only remove 50% of the accumulated 
plaque. Therefore the use of mouthrinses and other chemical plaque control methods is 
justifiable (Van der Weijden et al, 2008). Most mouthrinses used to control plaque mainly 
consist of an active ingredient or an antiseptic agent, ethanol (as a solvent) or water in addition to 
surfactants, humectants and flavorings (Addy and Moran, 2008). The most popular active 
ingredients are chlorhexidine, essential oils, cetylpyridinium chloride and the newly introduced 
carbohydrate fulvic acid (Addy and Moran, 2008). These ingredients can have bacteriocidal or 
bacteriostatic mechanisms of action (Addy and Moran, 2008). 
Mouthrinses have a wide range of uses, mainly as an adjuvant method to mechanical tooth 
brushing. It has been proven that some mouthrinses reduce halitosis via reduction of volatile 
sulphur compounds (Carvalho et al, 2004). Mouthrinses are often used in hospital settings as a 
supplement for mechanical tooth brushing for example with unconscious or disabled patient due 
to physical or mental inability or as a post-operative care measure. However, some of these 
mouthwashes have adverse effects either due to the active ingredient itself e.g. chlorhexidine or 
due to one of additive materials such as alcohol (Eldridge et al, 1998).  
In this study the antimicrobial efficacy of non-chlorhexidine non-alcohol (NC-NA) containing 
mouthrinses was tested against various oral microorganisms in vitro. 
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1.2 Literature review 
1.2.1 Chlorhexidine 
 
Chlorhexidine is a chemotherapeutic agent which is widely used as an adjunct to mechanical 
plaque control. It reduces plaque accumulation by 60 % (Bascones et al, 2005) and  is found in 
three different formulations; digluconate, acetate and hydrochloride (Addy and Moran, 2008). 
The chemical structure of chlorhexidine is complex, made up of two 4- chlorophenyl rings and 
two biguanide groups linked by a central hexamethyline chain. This makes it more basic in 
nature as it gains bicatonic charge which has high capacity for anionic elements (Bascones et al, 
2005). 
Mechanism of action and clinical efficacy 
Chlorhexidine acts as a bacteriostatic agent by increasing membranous permeability of 
microorganisms, thus altering potassium intracellular concentration (Bascones et al, 2005). It can 
also act through inhibiting proteolytic and glycocidic enzymes (Addy and Moran 2008).   At 
higher concentrations, chlorhexidine can be bacteriocidal by inducing cytoplasmic precipitation 
which eventually leads to cell death. 
 Due to its chemical structure chlorhexidine has the ability to be adsorbed by both hard and soft 
tissues to be slowly released over a period of 8 -12 hours. This is known as substantivity 
(Bascones et al, 2005).Thus it is the most clinically effective mouthrinse currently available 
(Bascones et al, 2005). 
In vitro, it was proven that chlorhexidine is effective against Gram-positive and Gram-negative 
microorganisms including aerobes and anaerobes, together with fungi. However, the gram 
negative anaerobes were decreased to a lesser degree. No resistance was observed against 
chlorohexidine despite long periods of usage extending up to two years (Addy and Moran 2008). 
Clinically chlorhexidine has two popular concentrations: 0.2 % and 0.12%, (Rath and Singh 
2013). A comparative study that was conducted between the two concentrations concluded that 
both have optimum clinical results. However, the adverse effects of chlorhexidine are dose and 
http://etd.uwc.ac.za
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concentration dependent. Therefore, the 0.12% concentration was recommended because of its 
better patient compliance (Rath and Singh 2013). 
It was reported that the use of 0.2 % mouthrinse shows 43% reduction in volatile sulphur 
compounds (VSC) values and 50% reduction in organoleptic halitosis ratings .De Boever and 
Loesche as cited by Perry et al, 2009 reported 73% VSC, 69% mouth odor and 78% tongue odor 
reductions when 0.12% concentration was used. 
Alcohol is added to some chlorhexidine preparations to act as an antiseptic and/ or as a solvent to 
carry other ingredients. (Eldridge et al, 1998; Borrajo et al, 2002). 
Adverse effects  
Although different concentrations of chlorhexidine are available; it was found that the adverse 
effects are dose dependent (Cancro et al, 1974) and concentration dependent (Greenstein et al, 
1986). Chlorhexidine has localized side effects which may appear due to prolonged usage. This 
is mainly reflected as brown staining of teeth, tongue and transient impairment of taste (Perry et 
al, 2010) and increased calculus formation (Rath et al, 2013). Allergies (type 1 hypersensitivity 
reaction) and allergic contact dermatitis and stomatitis (type 4 hypersensitivity reaction) were 
also reported (Pemberton and Gibson 2012). 
1.2.2Essential oils based mouthrinses 
Usually essential oils based mouthrinses include thymol (0.064 %), eucalyptol (0.092 %), 
menthol (0.042 %), and methylsalicylate (0.060 %) (Perry et al, 2009; Charles et al, 2012). 
Alcohol is added to essential oils preparations in a certain concentration that dissolves the 
essential oils but not enough to act as an antiseptic (Cortelli et al, 2013). 
The antiplaque and the antigingivitis effect of essential oils were reported by several clinical 
studies (Amini et al, 2009). They reduce plaque by 20% – 35% and gingivitis by 25%- 35% 
(Perry et al, 2010). Another study was conducted on the efficacy of essential oils and showed 
greater plaque reduction i.e. 56% and 35% gingivitis reduction when used alone without 
mechanical control (Amini et al, 2009). 
Essential oils based mouthrinses show immediate penetration of the biofilm as well as 
substantivity that lasted for 7 hours after application (Quintas et al, 2014). 
http://etd.uwc.ac.za
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A newly introduced Listerine Zero® (Johnson and Johnson Ltd.) mouthrinse is an essential oil 
based mouthrinse that does not contain alcohol (Cortelli et al, 2013). According to the 
manufacturers, they were able to develop new compounds that could stabilize the essential oils 
without the need for alcohol (Charles et al, 2012). A two weeks randomized control study was 
carried out to test the efficacy of Listerine Zero®; the results showed that there was a reduction 
by 23.9% and 10.4% in plaque and gingival indices respectively when compared to the control 
group (Charles et al, 2012). Another six month randomized clinical trial was carried out by 
Cortelli et al, 2013 where Listerine Zero® was compared to alcohol free cetylpyridinium. The 
study showed that Listerine Zero® reduced plaque and gingivitis by 31.6% and 4.4%. 
Adverse effects of using alcohol in both chlorhexidine and essential oils based mouthrinses 
Eldridge et al, 1998 showed that mouthrinses that contained less than 10% of alcohol did not 
induce pain, but there was concern about using alcohol at more than 24% because of the 
potential increase in the risk of oral and pharyngeal cancer in patients who used it on a daily 
basis. In addition, high ethanol concentrations, if combined with low pH of a mouthrinse, can 
cause irritation of oral mucosa. The authors recommended that these be contraindicated it in 
patients with mucositis. Alcohol can be an aggravating factor to the side effects of oral and neck 
radiotherapy such as xerostomia, ulcerating gingivitis and tissue damage (Borrajo et al, 2002; 
Bascones et al, 2005). Moreover, it is also contraindicated in immunocompromised patients and 
chronic alcoholic patients as it can increase the intensity of the side effects of alcohol abuse 
(Bascones et al, 2005). Lemos-Junior and Villoria (2008) also reported that mouthwashes, which 
contained 26.9 % ethanol, could be lethal for children weighing up to 26 pounds if 5 to 10 
ounces were ingested.   
1.2.3Cetylpyridinium chloride 
Cetylpyridinium chloride, also known as CPC is a quaternary ammonium compound with strong 
cationic properties, which readily binds to anionic particles (Cortesia et al, 2010). It acts 
primarily on Gram-positive bacteria and yeasts but some authors claim that it is antimicrobial 
against Gram-negative bacteria as well (Kang et al, 2012). 
CPC mouthrinse acts via increasing membrane permeability and decreasing cellular adherence of 
microorganisms (Kang et al, 2012). According to Amini et al, (2009) in a six-month trial, it had 
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24% antigingivitis and antiplaque effects. CPC efficacy may be increased if combined with 
chlorhexidine (Kang et al 2012). 
CPC can be found as alcohol combined as well as alcohol-free mouthrinse formulations. 
However, there is no significant difference between the efficacies of the two formulas as 
antiplaque being 6.2% and 9.4% or as antigingivitis being 6.1% and 5.8% respectively (Amini et 
al, 2009). It was found that  essential oils based mouthrinses have an in vitro antimicrobial effect 
two times greater than 0.05% CPC whether it is combined with alcohol or not (Amini et al 
2009). 
1.2.4 Carbohydrate derived fulvic acid 0.5% (CHD-FA)  
CHD-FA is a heat stable low molecular weight, water soluble, cationic, colloidal material with 
proposed therapeutic properties (Sherry et al, 2012). CHD-FA is an organic acid with proven 
efficacy against Candida albicans biofilms (Sherry et al, 2012) as well as bacterial oral films. It 
was developed in order to overcome the side effects of chlorhexidine and to modulate the 
immune response of the host (Sherry et al, 2013). 
CHD-FA mouthrinse has both bactericidal and bacteriostatic properties. It is active against 
various oral pathogenic organisms including Aggregabacter actinomycetemcomitans, 
Streptococcus mutans and mitis, Enterococcus faecalis, Fusobacterium nucleatum and 
Porphyromonas gingivalis (Sherry et al, 2013). When compared to chlorhexidine, none of the 
tested microorganisms used showed more sensitivity or resistance to either compound. However 
CHD-FA showed more rapid antimicrobial activity as after thirty minutes there was a reduction 
in the polymicrobial biofilm by 90% (Sherry et al, 2013). 
Moreover, CHD - FA displayed no toxicity when tested on rats and humans at pH of 7.0 and had 
anti-inflammatory and wound healing properties (Sherry et al, 2013, Grandy et al, 2012). Grandy 
et al, (2012) also reported that it was safe up to 40 ml of mouthrinse twice daily for a week. 
According to the available literature, there is insufficient data on the efficacy of NC-NA 
containing mouthrinses. 
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1.3 Aim and Objectives 
1.3.1 Aim: 
To compare the antimicrobial efficacy of three different NC-NA containing mouth rinses OTC, 
available locally.  
1.3.2 Objectives: 
To test the antimicrobial efficacy of: 
1. Resmed chlorhexidine gluconate® (Resmed Healthcare. South Africa). 
2. Listerine Zero ® (Johnson and Johnson Ltd.  South Africa). 
3. Colgate total ® (Colgate Palmolive Ltd. Thailand). 
4. Biobalance mouthwash® (Fulvicare Ltd. South Africa). 
Against: 
1. Staphylococcus aureus (ATCC25923). 
2. Streptococcus mutans (ATCC 25175). 
3. Candida albicans (ATCC 36810). 
4. Enterococcus faecalis (ATCC 29212). 
5. Facultative anaerobes prepared from oral rinse samples. 
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CHAPTER TWO 
MATERIALS AND METHODES 
 
2.1 Study design: 
An in-vitro analytical study of an exploratory nature was carried out. 
2.2 Study site: 
Oral and Dental Research Institute laboratory, Faculty of Dentistry, University of the Western 
Cape. 
2.3 Study participants: 
Oral rinse samples were randomly collected from 14 staff members from the University of the 
Western Cape, Faculty of Dentistry. All enrolled adult individuals were dentate or partially 
dentate and all were orally and systematically healthy. Exclusion criteria included dentulous 
individuals, smokers and snuff dippers and those who have used antibiotics, immunosuppressive 
or chemotoxic drugs during the past three months prior to sample collection. 
2.4 Collection and preparation of oral rinse samples: 
Participants were asked to rinse thoroughly for 60 seconds with 10 ml of sterile saline provided 
in a universal container and to return the rinse into the container (Samaranayake, 1986). 
2.5 Measurements of bacterial densities in oral rinse suspensions: 
The samples from participants were standardized using the McFarland standard scale for 
measuring bacterial densities in suspensions. The turbidity of the McFarland standard and the 
oral rinse suspension was compared by holding the oral rinse and McFarland Standard tubes up 
against the black and white bars printed on enclosed cards. Standardization was reached when 
the turbidity of the fluid inside the two suspensions matched the McFarland standard 1 turbidity 
tube (corresponding approximately to 3 X 108 CFU/ml).  
The McFarland Standard tubes contain latex particles suspended in a liquid buffer that are 
adjusted to an acceptable transmission range using a spectrophotometer, at a wave length of 
http://etd.uwc.ac.za
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either 600 or 625 nm. Bacterial suspensions with similar turbidity to a particular McFarland 
Standard are expected to produce approximate cell count densities. This method is used in a 
variety of identification or susceptibility kits (Borges et al, 2010). 
2.6 Preparation of oral rinse cultures: 
One hundred µl (100 µl) of each suspension was inoculated onto standard Brain Heart Infusion 
agar (BHI) plates within a quarter of an hour of the suspension preparation. Sterile glass-rods 
were used to spread the suspension evenly on the surface of the plate. Then the plates were 
incubated for 24 hours at 37̊C. 
2.7 Preparation of pure cultures: 
Cultures of Staphylococcus aureus (ATCC 25923), Streptococcus mutans (ATCC 25175), 
Candida albicans (ATCC 36810) and Enterococcus faecalis (ATCC 29212) were tested because 
they have a well-known role in the development of dental caries, candidiasis and primary 
endodontic lesions respectively. Cultures were incubated for 24 hours at 37ºC. A separate 
inoculum from each culture was prepared by suspension in saline using the direct colony 
suspension method. The suspension of the pure cultures was also standardized with the 
McFarland Standard 1 as described above. 
2.8 Disc infusion test to measure inhibition zones: 
70 agar plates were divided into 5 groups as follows: 
• Group A: 14 aerobic and facultative anaerobic bacteria cultured plates prepared from oral 
rinse samples.   
• Group B: 14 plates of pure cultures for Staphylococcus aureus bacteria. 
• Group C: 14 plates of pure cultures for Streptococcus mutans bacteria. 
• Group D: 14 plates of pure cultures for the fungus Candida albicans. 
• Group E: 14 plates of pure cultures for Enterococcus faecalis bacteria. 
 
2.9 Mouthrinses used in this study 
1. Listerine Zero® mouthrinse: essential oils with sodium fluoride (Resmed Healthcare. South 
Africa). 
http://etd.uwc.ac.za
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2. Colgate total® mouthrinse: sodium fluoride 0.05% (225 ppm F) and cetylpyridinium chloride 
0.075% (Johnson and Johnson Ltd.  South Africa). 
3. Biobalance mouthwash®: CHD-FA (20%) (Colgate Palmolive Ltd. Thailand). 
 4. Resmed chlorhexidine gluconate 0.2% mouthrinse®. (Fulvicare Ltd. South Africa), as a 
positive control. 
The next step was the insertion of the absorbent paper disks, 4 sterile, with 5 mm-diameter, 
obtained by patterned perforation of coffee filter paper for each of the 70 agar plates. All disks 
were immersed in equal time (1 min) in respective substances and then in sequence, deposited 
neatly on sterile gauze to remove liquid excess (Borges et al, 2010). The antibacterial effect of 
each mouthrinse product was measured in terms of the dimensions of the bacterial growth 
inhibition zone around the disks that occurred within 24 hours of incubation. (Figure 1). 
Inhibition zones were measured thrice from various points and angles using a digital caliber. 
(Figure 2). 
 
Figure 1: inhibition zones around the discs 
http://etd.uwc.ac.za
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Figure 2: digital caliber used in measurement 
 
2.10 Data analysis: 
The data was categorized and coded and then entered into a data capture sheet using Microsoft 
Excel sheet (Microsoft Corporation®, Redmond, Washington). The database was imported into 
Social Package of Statistical Analysis (SPSS-IBM Corporation®, Armonk, New York) to 
perform statistical analysis. A statistician was consulted and the results were presented 
appropriately in the form of frequency tables and graphs. 
2.11 Ethical approval: 
Ethical approval was obtained from the UWC, Faculty of Dentistry. Fourteen individual 
participants consent for specimen collection was obtained via written informed consent 
(Appendix 1, 2). The voluntary nature of the participation in this study was clearly explained to 
the participants, along with any potential advantage, disadvantage, compensation or complaints 
that might result due to taking part in this study.  The researcher's contact details were available 
to all participants for further information about the study or its outcome. 
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CHAPTER 3 
RESULTS 
 
The results obtained from each type of bacterial suspension that was co- cultured with each of 
the four types of mouthrinses in the fourteen different perti dishes and the mean measurement of 
the clear zone that was calculated are presented in Table 1.  
The results obtained from the saliva samples showed that the mean measurement of the clear 
zone was significantly higher when using Resmed chlorhexidine compared to other mouthrinses. 
Colgate Total® displayed the highest measurement. Whereas, no significant difference between 
Listerine Zero® and Biobalance mouthwash® was observed (Table 3.2, Fig 3.1). Similar results 
were obtained when Enterococcus faecalis was tested with each mouthrinse (Table 3.3, Fig. 3.2). 
 
Table 1: Mean measurement of clear zone in mm of the four types of mouthrinses co-cultured 
with sessile aerobes and facultative anaerobes obtained from saliva, S. aureus, S. mutans, C. 
albicans and E. faecalis 
 Chlorhexidine Colgate total Listerine Zero Biobalance 
mouthwash 
Oral flora 
obtained from 
saliva 10.27 7.95 0 0.57 
Staphylococcus 
aureus 19.55 13.6 1.23 7.10 
Streptococcus 
mutans 22.02 17.10 0 9.30 
Candida 
albicans 12.20 10.10 0 2.35 
Enterococcus 
faecalis 11.08 9.4 0 0 
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Table 2: The Mean measurement of the clear zone of sessile aerobes and facultative anaerobes 
obtained from saliva co-cultured with Resmed chlorhexidine 0.2%®, Colgate Total®, Listerine 
Zero® and Biobalance mouthwash® 
 
 Mean±SD P-value 
Resmed chlorhexidine 
0.2%® 
10.27±4.65a  
0.0001 
Colgate Total® 7.95±2.42b 
Listerine Zero® 0c 
Biobalance mouthwash® 0.57±2.14c 
(A, b): Means different superscripts are significant (p<0.05) 
 
Table 3: The Mean measurement of the clear zone of Enterococcus faecalis suspension co-
cultured with Resmed chlorhexidine 0.2%®, Colgate Total®, Listerine Zero® and Biobalance 
mouthwash® 
 Mean±SD P-value 
Resmed chlorhexidine 
0.2%® 
11.08±0.47a  
0.0001 
Colgate Total® 9.40±0.70b 
Listerine Zero® 0c 
Biobalance mouthwash® 0c 
(A, b): Means different superscripts are significant (p<0.05) 
Results from the Staphylococcus aureus, Streptococcus mutans and Candida albicans bacterial 
suspensions revealed that the mean measurement of the clear zone was significantly higher when 
using Chlorhexidine compared to other mouthwashes. Colgate total® showed higher 
measurement than both Listerine Zero® and Biobalance mouthwash® the mean clear zone 
measurement was significantly higher with Listerine Zero® than Biobalance mouthwash® 
(Tables 3.4, 3.5, 3.6, Figs 3.3, 3.4, 3.5) respectively.   
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Table 4: The Mean measurement of the clear zone of Staphylococcus aureus suspension co-
cultured with Resmed chlorhexidine 0.2%®, Colgate Total®, Listerine Zero® and Biobalance 
mouthwash® 
 Mean±SD P-value 
Resmed chlorhexidine 
0.2%® 
19.55±3.17a  
0.0001 
Colgate Total® 13.60±4.49b 
Listerine Zero® 1.23±4.59c 
Biobalance mouthwash® 7.09±5.94d 
(A, b): Means different superscripts are significant (p<0.05) 
Table 5: The mean measurement of the clear zone of Streptococcus mutans suspension co-
cultured with Resmed chlorhexidine 0.2%®, Colgate Total®, Listerine Zero® and Biobalance 
mouthwash® 
 Mean±SD P-value 
Resmed chlorhexidine 
0.2%® 
22.02±1.45a  
0.0001 
Colgate Total® 17.10±2.41b 
Listerine Zero® 0c 
Biobalance mouthwash® 9.31±1.62d 
(A, b): Means different superscripts are significant (p<0.05) 
Table 6: The Mean measurement of the clear zone of Candida albicans suspension co-cultured 
with Resmed chlorhexidine 0.2%®, Colgate Total®, Listerine Zero® and Biobalance 
mouthwash® 
 
 Mean±SD P-value 
Resmed chlorhexidine 
0.2%® 
12.20±0.96a  
0.0001 
Colgate Total® 10.10±1.94b 
Listerine Zero® 0c 
Biobalance mouthwash® 2.35±3.28d 
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(A, b): Means different superscripts are significant (p<0.05) 
 
Figure 3: The difference in the mean measurement of the clear zone of sessile aerobes and 
facultative anaerobes obtained from Saliva co-cultured with Resmed chlorhexidine 0.2%®, 
Colgate Total®, Listerine Zero® and Biobalance mouthwash®. 
 
Figure 4: The difference in the mean measurement of the clear zone of Enterococcus faecalis 
suspension co-cultured with Resmed chlorhexidine 0.2%®, Colgate Total®, Listerine Zero® and 
Biobalance mouthwash®. 
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Figure 5: The difference in the mean measurement of the clear zone of Staphylococcus aureus 
suspension co-cultured with Resmed chlorhexidine 0.2%®, Colgate Total®, Listerine Zero® and 
Biobalance mouthwash®. 
 
 
0
5
10
15
20 19,55
13,6
1,23
7,1
C
le
ar
 z
on
e 
in
 m
m
Staphylococcus aureus
http://etd.uwc.ac.za
22 
 
 
Figure 6:  The difference in the mean measurement of the clear zone of Streptococcus mutans 
suspension co-cultured with Resmed chlorhexidine 0.2%®, Colgate Total®, Listerine Zero® and 
Biobalance mouthwash®. 
 
 
Figure 7: The difference in the mean measurement of the clear zone of Candida albicans 
suspension co-cultured with Resmed chlorhexidine 0.2%®, Colgate Total®, Listerine Zero® and 
Biobalance mouthwash®. 
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CHAPTER FOUR 
DISCUSSION 
 
In this in-vitro study the antimicrobial efficacy of three different mouthrinses were tested against 
salivary oral flora and pure cultures of selected bacteria. None of these mouthrinses contained 
chlorhexidine or alcohol. The organisms used were obtained from two different sources i.e. 
standard laboratory strains as well as oral salivary rinse samples. The laboratory strains were 
selected based on their association with oral diseases and included Streptococcus mutans, 
Staphylococcus aureus, Candida albicans and Enterococcus faecalis.  
Aerobes and the facultative anaerobes were cultured from saliva that was collected from 14 staff 
members of Faculty of Dentistry, University of the Western Cape. This method was selected 
based on previous studies by Samaranayake (1986) that indicated that salivary rinse samples 
have the ability to represent all microorganisms present in the oral cavity including periodontal 
pathogens present in dental pockets. This allowed the investigator to determine the efficacy of 
the mouthrinses against oral microorganisms that originated from both a planktonic as well as a 
sessile state from the oral cavity.   
Based on the results obtained, the test mouthrinses showed different degrees of antimicrobial 
efficacy against the cultured microorganisms (Table 3.1).  These differences were statistically 
significant (p. value = 0.0001). The order in terms of antimicrobial efficacy against 
Streptococcus mutans, Staphylococcus aureus, Candida albicans, Enterococcus faecalis and 
aerobes and facultative an aerobes obtained from saliva is Colgate Total® ˃ Biobalance 
mouthwash® ˃ Listerine Zero®. 
Colgate Total® showed the greatest degree of antimicrobial efficacy, this antimicrobial 
dominance was displayed across the range of organisms tested including Streptococcus mutans, 
Staphylococcus aureus, Candida albicans, Enterococcus faecalis and the aerobic and facultative 
anaerobic organisms cultured from the collected oral saliva. The reason for the antimicrobial 
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efficacy of Colgate Total® seen in this study is not clear, but may be due to its active ingredient 
cetylpyridinium chloride (CPC). CPC has a broad antimicrobial spectrum largely based on its 
cationic chemical structure. This cationic property allows it to bind to anionic bacterial cell walls 
leading to disruption of the cellular membrane, leakage of the intracellular components, and 
eventual cell death (Kang et al, 2015; Almas et al, 2005). The efficacy of CPC against Candida 
albicans has been demonstrated in several in-vitro and in-vivo studies with the present study 
showing similar efficacy as was previously mentioned in the literature. The exact mechanism of 
action against Candida albicans is poorly understood but it is thought to be related to an 
interaction with the fungal cell wall (Pizzo et al, 2001). Recent research also indicates that CPC 
has the ability to reduce the attachment of Candida albicans to epithelial cell walls (Pizzo et al, 
2001). 
Biobalance mouthwash® was the second most effective mouthrinse in terms of antimicrobial 
efficacy. It has CHD-FA as an active ingredient which acts via disrupting the bacterial and 
fungal cellular membranes leading to lysis and eventually death. (Sherry et al, 2012; Sherry et al, 
2013).  
According to Sherry et al, 2013 CHD-FA has a broad spectrum of antimicrobial activity against 
oral pathogens in both planktonic and sessile forms as well as laboratory designed biofilms. 
However, in this study mouthrinse containing CHD-FA failed to obtain significant antimicrobial 
efficacy against Enterococcus faecalis colonies, the reason behind this is unknown. On the other 
hand the same mouthrinse showed significant amount of reduction in other microorganisms 
tested in the study. It is worth mentioning that the concentration of CHD-FA used in this study 
was 20% which is higher concentration than that used by Sherry et al, 2013.Whether this had any 
significance is unknown. 
 Listerine Zero® utilizes essential oils as active ingredients. They act via penetrating the biofilm 
and disrupting the intercellular bonds of plaque forming microorganisms (Quintas et al, 2014). In 
this study Listerine Zero® failed to show any significant antimicrobial efficacy against 
microorganisms tested. A 6 month randomized control study was carried out Cortelli et al to 
compare the antimicrobial efficacy of alcohol free essential oil with CPC containing mouthrinses 
in terms of reduction of plaque and gingivitis.  They found that alcohol free essential oil 
containing mouthrinse reduced plaque and gingivitis by 16.1% and 6.7% respectively. While 
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CPC reduced plaque and gingivitis by 6.9% and 5.1% respectively (Cortelli et al, 2013).  The 
variation in terms of results between Cortelli et al, 2013 and this study might be due to the 
absence of intercellular bonds which is significant to the plaque biofilm. 
 Absence of alcohol might be another reason why Listerine Zero® did not show significant 
antimicrobial efficacy against microorganisms tested in this study. It is worth mentioning that 
alcohol is a major constituent in other Listerine® mouthrinses.    
Difference in concentrations of active ingredients and other additive materials that may interfere 
with the chemical formula of active ingredients are considerable factors that might contribute to 
these findings.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
http://etd.uwc.ac.za
26 
 
 
CHAPTER FIVE 
Conclusions 
 
Colgate total® showed antimicrobial efficacy against all microorganisms tested whereas 
Biobalance mouthwash® failed to show significant antimicrobial efficacy against Enterococcus 
faecalis, though it was successful in showing significant results against other microorganisms 
tested in the study. Listerine Zero® failed to accomplish significant antimicrobial efficacy 
against tested microorganisms and the reasons behind that is unknown.  
Results of this study can act as a platform for further clinical investigations regarding the use of 
NC-NA containing mouthrinses as a novelty treatment for dental patients.  
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CHAPTER 6 
Limitations 
 
Microorganisms suspended from oral rinse samples do not possess the biofilmatic properties of 
dental plaque, which may have had interference with the mechanism of action of some active 
ingredients of mouthrinses used in the study. Plaque defensive mechanisms against active 
ingredients in mouthrinses were not counted for in this study. Finally oral flora obtained from 
oral rinse samples (aerobes and facultative anaerobes) were dealt with collectively, sensitivity of 
specific bacterial colonies was not tested.  
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Appendix 1 
Information Sheet 
 
Efficacy of non-chlorhexidine non- alcohol containing mouth rinses: an in-vitro analysis 
I am Dr. A. Abdelhadi, a postgraduate dental student at the faculty of Dentistry, University of 
Western Cape. 
I would like to invite you to take part in a research study. Before you decide, you need to 
understand why the research is being done and what it would involve for you. Please take time to 
read the following information carefully. Ask questions if anything you read is not clear or 
would like more information. Take time to decide whether or not to take part. 
What is the purpose of the study? 
This study is aiming to measure the antimicrobial efficacy of three different NC-NA containing 
mouthwashes. These mouthwashes are available in local markets and have been marketed as 
being effective in inhibiting oral bacteria to more or less similar degrees. 
Why have I been invited? 
You have been invited to participate in this research because you satisfy the inclusion criteria of 
the study, which states that individuals who are dentate (have the full set of teeth) or partially 
dentate and systemically healthy are eligible to participate. Sampling of participants is meant to 
be random, i.e. no specific ethnic group or gender is targeted more than the rest of the 
population. If you are a smoker, diabetic, pregnant, have other medical/genetic conditions (as 
will be explained by the examiner), under antibiotic treatment at the moment or during the past 
three months, or you have no natural teeth left, then you are unsuitable to participate in this study 
(but anyway, thanks for your time!). 
Do I have to take part? 
It is up to you to decide. We will describe the study and go through the information sheet, which 
we will give to you. We will then ask you to sign a consent form to show you agreed to take part. 
You are free to withdraw at any time, without giving a reason. 
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What will happen to me if I take part? 
10 ml of sterile normal phosphate buffered saline will be offered to you to rinse your mouth with. 
You are expected to rinse for 60 seconds in the presence of the researcher. This procedure is 
totally painless and no bleeding or tissue damage will ensue afterwards. Collected oral rinse 
samples will then be sent for microbiological study in the laboratory to culture different bacteria 
that are commonly found in the mouth. You will be referred to the appropriate department within 
our faculty in case any dental or oral disease that needs treatment is detected. 
Participating in this study will cost you nothing; in fact it might save you money by the early 
detection of any dental or oral lesions which makes treatment easier and cheaper. 
What will I have to do? 
 For the purposes of this study, nothing more is required from you. However, regular visits to the 
dentist in addition to sustained efforts to clean your teeth (by brushing and flossing) will always 
be encouraged if you want to stay healthy and keep your teeth in good shape. 
What are the possible disadvantages and risks of taking part? 
No perceived disadvantages or risks are expected to result from taking part in this study. 
What are the possible benefits of taking part? 
We cannot promise the study will help you, but the information we get from the study will help 
to increase the understanding of the microbiology of oral fungal infections, gum disease and 
dental caries. 
What if there is a problem? 
If you have a concern about any aspect of this study, you should ask to speak to the researcher 
who will do his best to answer your questions (contact number: 0783125655).  
If you remain unhappy and wish to complain formally, you can do this through Professor LXG 
Stephen, diagnostic cluster chairperson, Faculty of Dentistry, University of Western Cape. 
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Will my taking part in the study be kept confidential? 
All information which is collected about you during the course of the research will be kept 
strictly confidential, and any information about you which leaves the hospital will have your 
name and address removed so that you cannot be recognized.  
How your data will be collected? 
Samples collected from you as a participant will be given a code known only to the researcher 
before being sent for laboratory examination. A master list identifying participants to the 
research codes data will be held on a password protected computer accessed only by the 
researcher. Hard paper will be stored in a locked cabinet, within locked office, accessed only by 
the researcher. Electronic data will be stored on a password protected computer known only by 
the researcher. Your data will be accessible only to authorized persons such as researchers within 
the team, supervisors, sponsors and for monitoring the quality, regulatory authorities /R&D 
audit. Your data will be retained for a period of 3 years before it will be disposed of securely. 
What will happen if I don’t carry on with the study? 
If you withdraw from the study we will destroy all your identifiable samples, but we will need to 
use the data collected up to your withdrawal.  
What will happen to the results of the research study? 
The results of this research study will be submitted as a thesis for a master degree, and if the 
degree is approved by the university senate, I intend to publish these results in dental research 
journals. These results can be made available to you by sending it via e-mails if you wish to be 
notified by the outcome of the study.  We confirm again that you will not be identified in any 
report/publication unless you have given your personal consent. 
Who is organizing or sponsoring the research? 
The University of the Western Cape represented by two departments –the Department of Oral 
Medicine and Periodontics, and the Department of Medical Biosciences- will be organizing and 
sponsoring this research project. 
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Further information and contact details: 
1. General information can be found at medical research websites like www.pubmed.gov or 
www.cdc.gov  
2. For specific information about this research project, you are welcome to contact me at 
this e-mail address 3412536@uwc.ac.za  
This study has been ethically reviewed and approved by the UWC Senate Biomedical Research 
Ethics Committee (approval number_____). 
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Appendix 2 
Informed consent 
 
I, (Name…………………………….) have been informed about the study entitled the 
antimicrobial efficacy of three non-chlorhexidine non-alcohol containing mouth rinses: an in-
vitro analysis, by Dr. A. Abdelhadi. 
I understand the purpose and procedures of the study. 
I have been given an opportunity to ask questions about the study and have had answers to my 
satisfaction. 
I declare that my participation in this study is entirely voluntary and that I may withdraw at any 
time without affecting any treatment or care that I would usually be entitled to. 
If I have any further questions/concerns or queries related to the study I understand that I may 
contact the researcher at cell phone number (078)312-5655 or via e-mail 3412536@myuwc.ac.za 
If I have any questions or concerns about my rights as a study participant, or if I am concerned 
about an aspect of the study or the researchers then I may contact:  
DENTISTRY RESEARCH ETHICS COMMMITTEE 
Research Office, Tygerberg Campus 
Francie van Zyl Drive 
Private Bag X1  
Tygerberg 7505 
Cape Town, SOUTH AFRICA 
 
____________________      ____________________ 
Signature of Participant                            DateReferences 
